摘要
目的 研究对萨摩亚地区糖尿病视网膜病变合并黄斑水肿患者在治疗中应用实施玻璃体腔注射抗VEGF药物与视网膜激光光凝治疗时所展现的临床实施效果与实施价值。方法 本次研究的病例数为128例,他们均来自于2024年1月-2024年6月期间萨摩亚TTM医院收治的糖尿病视网膜病变合并黄斑水肿患者,根据治疗方法的不同将所有患者分为对照组和观察组,其中对照组应用视网膜激光光凝术,观察组在对照组的基础上联合玻璃体腔注射抗VEGF药物治疗,并对两组患者的治疗效果、视网膜厚度、最佳矫正视力、眼压、SDF-1、VEGF、PDGF、CLVQOL以及并发症发生率进行对比分析。结果 经干预后观察组患者的治疗总有效率更高,差异具有统计学意义(P<0.05);观察组患者的视网膜厚度、最佳矫正视力、眼压更好,差异具有统计学意义(P<0.05);观察组患者的CLVQOL评分更高,差异具有统计学意义(P<0.05);两组患者的并发症发生率无明显差异(P>0.05)。结论 对萨摩亚地区糖尿病视网膜病变合并黄斑水肿患者在治疗中联合玻璃体腔注射抗VEGF药物与视网膜激光光凝治疗的临床治疗效果优势明显,能够有效改善患者的视网膜厚度、最佳矫正视力、眼压和CLVQOL评分,值得在临床上进行推广。
关键词: 玻璃体腔;抗VEGF药物;视网膜激光光凝术;糖尿病视网膜病变;黄斑水肿
Abstract
Objective: To study the clinical effect and implementation value of intravitreal injection of anti-VE GF drugs and retinal laser photocoagulation in patients with diabetic retinopathy complicated with macular edema in Samoa. Methods: The number of cases in this study was 128, They were all from patients with diabetic retinopathy complicated with macular edema admitted to the TTM Hospital in Samoa between January 2024 and June 2024, All patients were divided into control and observation groups according to the different treatment methods, In which the control group applied retinal laser photocoagulation, The observation group was combined with intravitreal injection of anti-VE GF drugs based on the control group, And a comparative analysis of the treatment effect, retinal thickness, best corrected visual acuity, intraocular pressure, SDF-1, VE GF, PDGF, CLVQOL, and complication rate in both groups. Results: After intervention, the overall response rate was higher and statistically significant (P <0.05); better retinal thickness, best corrected visual acuity, and IOP were statistically significant (P <0.05); higher CLVQOL score and statistically significant (P <0.05); and no significant difference in complication rate between the two groups (P> 0.05). Conclusion : The treatment of patients with diabetic retinopathy with macular edema combined with VE GF drugs and retinal laser photocoagulation has obvious advantages, which can effectively improve the retinal thickness, best corrected visual acuity, intraocular pressure and CLVQOL score, and is worth promoting in clinical practice.
Key words: Vitreo; Anti-VE GF drug; Retinal laser photocoagulation; Diabetic retinopathy; Macular edema
参考文献 References
[1] 陈芬芬,蒋赛珍,刘方艳.预备控制护理联合积极共情反馈干预在玻璃体切除术联合视网膜激光光凝术患者中的应用效果[J].医疗装备,2024,37(10):147-149+153.
[2] 于飞鸿,赵琳,杨斯崇.抗血管内皮生长因子联合全视网膜激光光凝术治疗新生血管性青光眼的临床效果[J].中国社区医师,2024,40(05):38-40.
[3] 郑晖,赵晓静.玻璃体腔注射抗血管内皮生长因子、全视网膜激光光凝术先后应用顺序不同治疗重度非增殖期糖尿病视网膜病变的效果比较[J].中国社区医师,2024, 40(05):14-16.
[4] 饶文蓉,谢汤寿,杨林.全视网膜激光光凝术联合抗血管内皮生长因子药物治疗糖尿病相关的新生血管性青光眼的应用效果[J].糖尿病新世界,2024,27(04):16-19.
[5] 伏海昕,朱振涛,王洁,等.全视网膜激光光凝术治疗老年糖尿病视网膜病变的预后及影响因素[J].中国临床保健杂志,2023,26(06):762-765.
[6] 梁晓茜,陈王灵,陈运信,等.雷珠单抗辅助视网膜激光光凝治疗糖尿病视网膜病变伴玻璃体积血的疗效及对患者视力和HbA1c、mAlb水平的影响[J].中国医学装备,2023,20(08):88-92.
[7] 徐象周,李泓彬,翁宏武,等.局灶视网膜激光光凝术联合阿柏西普眼内注射溶液经玻璃体腔注射治疗局灶型糖尿病性黄斑水肿的疗效[J].医疗装备,2023,36(06):1-4.
[8] 陈俊卿,刘博,张蕊,等.视网膜激光光凝术联合雷珠单抗对视网膜中央动脉血流动力学及血清中VEGF、PDGF和炎性因子水平的影响[J].中国卫生检验杂志,2023, 33(03): 312-315.
[9] 冯希敏,张凤妍,祁颖,等.重度非增生型糖尿病视网膜病变患者经抗VEGF联合全视网膜激光光凝术治疗后黄斑水肿转归与术前糖化血红蛋白水平的关系[J].眼科新进展,2022,42(09):709-713.
[10] 张英楠,傅永艳,任红,等.雷珠单抗联合视网膜激光光凝术对BRVO继发黄斑水肿患者视网膜电图P1波及生活质量的影响[J].现代生物医学进展,2021,21(02):264-268.